PHS
KRTX

PFM Health Sciences’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

PFM Health Sciences’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-130,293
Closed -$41.2M – 90
2023
Q4 		$41.2M Sell
130,293
-7,916
-6% -$1.54M 2.47% 12
2023
Q3 		$23.4M Hold
138,209
– – 1.1% 39
2023
Q2 		$30M Hold
138,209
– – 1.16% 39
2023
Q1 		$25.1M Buy
138,209
+7,916
+6% +$1.51M 1.11% 38
2022
Q4 		$25.6M Hold
130,293
– – 0.92% 43
2022
Q3 		$29.3M Hold
130,293
– – 1.06% 45
2022
Q2 		$16.5M Sell
130,293
-76,823
-37% -$8.83M 0.63% 51
2022
Q1 		$26.3M Buy
207,116
+30,025
+17% +$3.38M 0.98% 42
2021
Q4 		$23.2M Hold
177,091
– – 0.79% 46
2021
Q3 		$21.7M Sell
177,091
-16,295
-8% -$1.88M 0.64% 51
2021
Q2 		$22M Buy
193,386
+14,540
+8% +$1.7M 0.69% 47
2021
Q1 		$21.5M Buy
+178,846
New +$20.3M 0.66% 51
2020
Q4 		– Sell
-137,960
Closed -$10.7M – 108
2020
Q3 		$10.7M Sell
137,960
-214,585
-61% -$18.3M 0.49% 59
2020
Q2 		$39.3M Sell
352,545
-146,965
-29% -$12.8M 2.04% 16
2020
Q1 		$36M Sell
499,510
-103,041
-17% -$8.81M 2.95% 10
2019
Q4 		$45.4M Buy
602,551
+191,908
+47% +$8.41M 2.16% 18
2019
Q3 		$6.7M Sell
410,643
-362,388
-47% -$7.04M 0.2% 62
2019
Q2 		$14.2M Buy
+773,031
New +$15.5M 0.27% 74

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

PFM Health Sciences's KRTX Position: Q1 2024 in Review

PFM Health Sciences sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 130,293 shares — an estimated $41.2M sold.

PFM Health Sciences first reported a position in KRTX in Q2 2019 and held it in 18 quarters. The position peaked at $45.4M in Q4 2019. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • PFM Health Sciences reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • PFM Health Sciences sold 130,293 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $41.2M.
  • PFM Health Sciences first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2019 and held it in 18 quarters.
  • PFM Health Sciences's Karuna Therapeutics, Inc. Common Stock position peaked at $45.4M in Q4 2019.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on PFM Health Sciences's 13F filing for Q1 2024, filed 14 May 2024.